Manufacturers Life Insurance Company, The Atara Biotherapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.44 - $1.22 $126,275 - $350,126	286,989 Added 1140.02%	312,163 $215,000
Q4 2023 Feb 13, 2024	SELL	$0.23 - $1.74 $4,119 - $31,166	-17,912 Reduced 41.57%	25,174 $12,000
Q2 2023 Aug 11, 2023	BUY	$1.5 - $3.04 $9,139 - $18,522	6,093 Added 16.47%	43,086 $69,000
Q4 2022 Aug 11, 2023	SELL	$2.85 - $5.18 $607 - $1,103	-213 Reduced 0.57%	36,993 $121,000
Q4 2022 Feb 13, 2023	SELL	$2.85 - $5.18 $607 - $1,103	-213 Reduced 0.57%	36,993 $121,000
Q3 2022 Aug 11, 2023	BUY	$2.85 - $8.73 $76 - $235	27 Added 0.07%	37,206 $140,000
Q3 2022 Nov 03, 2022	BUY	$2.85 - $8.73 $76 - $235	27 Added 0.07%	37,206 $141,000
Q2 2022 Aug 11, 2023	BUY	$4.69 - $9.84 $8,446 - $17,721	1,801 Added 5.09%	37,179 $289,000
Q2 2022 Aug 15, 2022	BUY	$4.69 - $9.84 $8,446 - $17,721	1,801 Added 5.09%	37,179 $290,000
Q1 2022 Aug 11, 2023	SELL	$8.44 - $16.89 $13,630 - $27,277	-1,615 Reduced 4.37%	35,378 $328,000
Q1 2022 May 20, 2022	SELL	$8.44 - $16.89 $70,988 - $142,061	-8,411 Reduced 19.21%	35,378 $329,000
Q4 2021 Feb 16, 2022	BUY	$14.7 - $19.89 $6,423 - $8,691	437 Added 1.01%	43,789 $690,000
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $38,655 - $57,709	-3,224 Reduced 6.92%	43,352 $776,000
Q2 2021 Aug 12, 2021	BUY	$12.89 - $16.58 $18,084 - $23,261	1,403 Added 3.11%	46,576 $724,000
Q1 2021 May 03, 2021	BUY	$14.0 - $20.72 $4,970 - $7,355	355 Added 0.79%	45,173 $649,000
Q4 2020 Feb 12, 2021	BUY	$12.67 - $26.23 $47,208 - $97,732	3,726 Added 9.07%	44,818 $880,000
Q3 2020 Nov 09, 2020	BUY	$11.92 - $15.87 $79,673 - $106,075	6,684 Added 19.43%	41,092 $533,000
Q2 2020 Aug 10, 2020	BUY	$7.53 - $14.93 $8,463 - $16,781	1,124 Added 3.38%	34,408 $476,000
Q1 2020 May 15, 2020	BUY	$5.69 - $17.78 $13,394 - $41,854	2,354 Added 7.61%	33,284 $283,000
Q4 2019 Feb 14, 2020	SELL	$10.89 - $16.79 $2,167 - $3,341	-199 Reduced 0.64%	30,930 $509,000
Q3 2019 Nov 12, 2019	BUY	$12.03 - $19.94 $41,094 - $68,115	3,416 Added 12.33%	31,129 $419,000
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $7,848 - $16,908	412 Added 1.51%	27,713 $557,000
Q1 2019 May 13, 2019	BUY	$28.4 - $41.74 $49,529 - $72,794	1,744 Added 6.82%	27,301 $1.09 Million
Q4 2018 Feb 14, 2019	SELL	$30.9 - $42.97 $51,541 - $71,673	-1,668 Reduced 6.13%	25,557 $888,000
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $96,177 - $119,364	-2,744 Reduced 9.16%	27,225 $1.13 Million
Q2 2018 Aug 14, 2018	BUY	$35.15 - $51.45 $192,059 - $281,122	5,464 Added 22.3%	29,969 $1.1 Million
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $51,858 - $139,296	2,881 Added 13.32%	24,505 $955,000
Q4 2017 Feb 08, 2018	BUY	$13.2 - $18.1 $17,503 - $24,000	1,326 Added 6.53%	21,624 $391,000
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $268,948 - $346,080	20,298	20,298 $337,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account